A reproducible mock regulatory dossier for a fictional anti-TL1A / IL-22 bispecific antibody for moderate-to-severe ulcerative colitis — 98 documents organized by ICH CTD module. For demonstration only; not medical or regulatory advice.
📖 Start with the Reader's Guide →